摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-甲氧基苯基乙酸乙酯 | 35553-92-5

中文名称
3-甲氧基苯基乙酸乙酯
中文别名
3-甲氧基苯乙酸乙酯;2-(3-甲氧基苯基)乙酸乙酯
英文名称
ETHYL 3-METHOXYPHENYLACETATE
英文别名
ethyl 2-(3-methoxyphenyl)acetate
3-甲氧基苯基乙酸乙酯化学式
CAS
35553-92-5
化学式
C11H14O3
mdl
MFCD00026897
分子量
194.23
InChiKey
XXVVNHCWPHMLEZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    125-126 °C(Solv: ethanol (64-17-5))
  • 沸点:
    82 °C
  • 密度:
    1.062±0.06 g/cm3(Predicted)
  • 闪点:
    109-110°C/1mm
  • 稳定性/保质期:
    常规情况下不会分解,没有危险反应。

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    14
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.363
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 安全说明:
    S24/25
  • 海关编码:
    2918990090
  • 危险性防范说明:
    P264,P270,P301+P312,P330
  • 危险性描述:
    H302
  • 储存条件:
    密封保存于阴凉干燥处

SDS

SDS:cecc6a55a79ca2012e704d83ac86814e
查看
Name: Ethyl 2-(3-methoxyphenyl)acetate 97% Material Safety Data Sheet
Synonym:
CAS: 35553-92-5
Section 1 - Chemical Product MSDS Name:Ethyl 2-(3-methoxyphenyl)acetate 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
35553-92-5 Ethyl 2-(3-methoxyphenyl)acetate 97% 252-614-5
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 35553-92-5: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: red - orange
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 109 - 110 deg C
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C11H14O3
Molecular Weight: 194

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, bases.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 35553-92-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Ethyl 2-(3-methoxyphenyl)acetate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 35553-92-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 35553-92-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 35553-92-5 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    3-甲氧基苯基乙酸乙酯氯磺酸氯化亚砜 作用下, 以 二氯甲烷 为溶剂, 以12.6 g的产率得到ethyl 2-(2-(chlorosulfonyl)-5-methoxyphenyl)acetate
    参考文献:
    名称:
    一类RORγ抑制剂、其制备方法及其在医药上的应用
    摘要:
    本说明书提供了具有化学式(I)的化合物:或其药学上可接受的盐、氘代化合物、互变异构体、顺反异构体、内消旋体、外消旋体、对映异构体、非对映异构体或其混合物,用于制备此类化合物的方法,以及此类化合物作为RORγ抑制剂的用途。
    公开号:
    CN113912597B
  • 作为产物:
    描述:
    间羟基苯甲醛吡啶sodium hydroxide氯化亚砜乙醇硫酸 、 sodium iodide 作用下, 生成 3-甲氧基苯基乙酸乙酯
    参考文献:
    名称:
    364.合成与甾醇有关的物质的实验。第七部分
    摘要:
    DOI:
    10.1039/jr9350001533
点击查看最新优质反应信息

文献信息

  • Copper-Catalyzed Ullmann-Type Coupling and Decarboxylation Cascade of Arylhalides with Malonates to Access α-Aryl Esters
    作者:Fei Cheng、Tao Chen、Yin-Qiu Huang、Jia-Wei Li、Chen Zhou、Xiao Xiao、Fen-Er Chen
    DOI:10.1021/acs.orglett.1c03688
    日期:2022.1.14
    We have developed a high-efficiency and practical Cu-catalyzed cross-coupling to directly construct versatile α-aryl-esters by utilizing readily available aryl bromides (or chlorides) and malonates. These gram-scale approaches occur with turnovers of up to 1560 and are smoothly conducted by the usage of a low catalyst loading, a new available ligand, and a green solvent. A variety of functional groups
    我们开发了一种高效实用的铜催化交叉偶联,通过利用容易获得的芳基溴化物(或氯化物)和丙二酸盐直接构建多功能的 α-芳基酯。这些克级方法的周转率高达 1560,并且通过使用低催化剂负载、新的可用配体和绿色溶剂顺利进行。可以耐受多种官能团,并且使用 α-芳基酯来获得克级的非甾体抗炎药 (NSAID)。
  • [EN] P300/CBP HAT INHIBITORS<br/>[FR] INHIBITEURS D'HAT P300/CBP
    申请人:CONSTELLATION PHARMACEUTICALS INC
    公开号:WO2019161162A1
    公开(公告)日:2019-08-22
    Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with histone acetyltransferase (HAT).
    提供的是Formula (I)的化合物及其药用可接受的盐和组合物,可用于治疗与组蛋白乙酰转移酶(HAT)相关的各种疾病。
  • Boron-Catalyzed O–H Bond Insertion of α-Aryl α-Diazoesters in Water
    作者:Htet Htet San、Shi-Jun Wang、Min Jiang、Xiang-Ying Tang
    DOI:10.1021/acs.orglett.8b01988
    日期:2018.8.3
    A catalytic, metal-free O–H bond insertion of α-diazoesters in water in the presence of B(C6F5)3·nH2O (2 mol %) was developed, affording a series of α-hydroxyesters in good to excellent yields. The reaction features easy operation and wide substrate scope, and importantly, no metal is needed as compared with the conventional methods. Significantly, this approach further expands the applications of
    在存在B(C 6 F 5)3 · n H 2 O(2摩尔%)的条件下,开发了水中无催化的α-重氮酸酯插入金属的O–H键,从而获得了一系列的α-羟基酯。好到极好的产量。该反应具有易于操作和广泛的底物范围的特​​点,重要的是,与常规方法相比,不需要金属。重要的是,这种方法进一步扩展了B(C 6 F 5)3在耐水条件下的应用。
  • Lewis Base Catalyzed Asymmetric Hydrosilylation of α-Substituted β-Enamino Esters: Facile Access to Enantioenriched β2-Amino Esters via Dynamic Kinetic Resolution
    作者:Xiao-Mei Zhang、Chang Shu、Xiao-Yan Hu、Shuai-Shuai Li、Wei-Cheng Yuan
    DOI:10.1055/s-0034-1378323
    日期:——
    A chiral Lewis base organocatalyzed asymmetric hydrosilylation of α-substituted β-enamino esters is presented. The reactions proceeded through dynamic kinetic resolution to afford various enantioenriched β2-amino esters with high yields (up to 98%) in moderate enantioselectivities (up to 77% ee).
    介绍了手性路易斯碱有机催化的 α-取代 β-烯氨基酯的不对称氢化硅烷化。反应通过动态动力学拆分进行,以中等对映选择性(高达 77% ee)以高产率(高达 98%)提供各种富含对映体的 β2-氨基酯。
  • Non-nucleoside reverse transcriptase inhibitors
    申请人:Roche Palo Alto LLC
    公开号:US20040192704A1
    公开(公告)日:2004-09-30
    This invention relates to novel heterocyclic compounds of formula I wherein R 1 —R 4 , X 1 and X 2 are as defined in the summary and pharmaceutically acceptable salts and solvates thereof, methods to inhibit or modulate Human Immunodeficiency Virus (HIV) reverse transcriptase with compounds of formula I, pharmaceutical compositions containing of formula I admixed with at least one solvent, carrier or excipient and processes to prepare compounds of formula I. The compounds are useful for treating disorders in which HIV and genetically related viruses are implicated 1
    这项发明涉及公式I的新异环化合物,其中R1-R4、X1和X2如摘要中所定义,并且其药用可接受盐和溶剂化合物,用公式I的化合物抑制或调节人类免疫缺陷病毒(HIV)逆转录酶的方法,含有公式I的药物组合物,与至少一种溶剂、载体或赋形剂混合,并制备公式I的化合物的方法。这些化合物可用于治疗HIV和遗传相关病毒参与的疾病。
查看更多